Emerald Advisers’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.27M | Buy |
|
|||||
|
2024
Q4 | $1.61M | Buy |
|
|||||
|
2024
Q3 | $1.04M | Buy |
|
|||||
|
2024
Q2 | $676K | Buy |
|
|||||
|
2024
Q1 | $240K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $419K | Sell |
|
|||||
|
2023
Q2 | $404K | Sell |
|
|||||
|
2023
Q1 | $1.7M | Sell |
|
|||||
|
2022
Q4 | $2.05M | Sell |
|
|||||
|
2022
Q3 | $1.78M | Buy |
|
|||||
|
2022
Q2 | $281K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $1.82M | Sell |
|
|||||
|
2020
Q3 | $1.55M | Buy |
|
|||||
|
2020
Q2 | $1.71M | Sell |
|
|||||
|
2020
Q1 | $1.32M | Sell |
|
|||||
|
2019
Q4 | $1.75M | Buy |
|
|||||
|
2019
Q3 | $842K | Buy |
|
|||||
|
2019
Q2 | $1.53M | Sell |
|
|||||
|
2019
Q1 | $6.54M | Sell |
|
|||||
|
2018
Q4 | $8.34M | Sell |
|
|||||
|
2018
Q3 | $34.7M | Sell |
|
|||||
|
2018
Q2 | $39.6M | Sell |
|
|||||
|
2018
Q1 | $29.9M | Sell |
|
|||||
|
2017
Q4 | $49.4M | Sell |
|
|||||
|
2017
Q3 | $40.5M | Buy |
|
|||||
|
2017
Q2 | $29.5M | Buy |
|
|||||
|
2017
Q1 | $24.2M | Buy |
|
|||||
|
2016
Q4 | $15M | Buy |
|
|||||
|
2016
Q3 | $15.3M | Buy |
|
|||||
|
2016
Q2 | $4.49M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $11.7M | Buy |
|
|||||
|
2015
Q2 | $10.7M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $8.45M | Buy |
|
|||||
|
2014
Q2 | $11M | Buy |
|
|||||
|
2014
Q1 | $6.62M | Sell |
|
|||||
|
2013
Q4 | $9.14M | Buy |
|
|||||
|
2013
Q3 | $18.1M | Sell |
|
|||||
|
2013
Q2 | $16M | Buy |
|